AGL - Agilon Health falls on new short report from Citron Research
- Agilon Health ( NYSE: AGL ) dropped 5.7% after Citron Research released a new short report with downside to $5/share.
- Citron alleges that Agilon has a "nosebleed" valuation relative to its peers and it has a problematic business model.
- Developing story ...
For further details see:
Agilon Health falls on new short report from Citron Research